Fact sheet: GAM Star India Equity

Fund information

Fund name
GAM Star India Equity Inst Acc USD
Fund company manager
GAM Fund Management Ltd
Fund type
SIB
Fund manager(s)
New Horizon Wealth Management
since 31/12/2014
Fund objective
To generate returns through first preserving and second growing capital by investing in a concentrated portfolio of publicly listed Indian companies.
Benchmark
MSCI India
Investment style
Growth
Investment method
Shares

Quick stats

1 Year return

14.14 %

1 Year rank in sector

25/50

Sector

FO Equity - India

Yield
-
Fund size

£ 45.8 m

FE Risk score
-
NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • India
    86.4%
  • Money Market
    13.6%
  • Financials
    38.41%
  • Consumer Discretionary
    18.23%
  • Net Current Assets
    13.6%
  • Health Care
    10.12%
  • Consumer Staples
    7.96%
  • Indian Equities
    86.4%
  • Money Market
    13.6%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund-1.5 %9.29 %14.14 %0 %0 %
Sector-0.74 %6.78 %13.88 %34.95 %66.3 %
Rank within sector37 / 4918 / 5125 / 50 / /
Quartile th4 th2 nd2 nd th th

Calendar performance

YTD-20172016201520142013
Fund31.37 %-0.95 %-3 %0 %0 %
Sector25.64 %3.79 %-1.79 %34.73 %-6.45 %
Rank within sector15 / 5038 / 4633 / 45 / /
Quartile th2 nd4 th3 rd th th

Price movement

52 week high12.8496
52 week low9.4002
Current bid price0
Current offer price0
Current mid price12.6223

Holdings by region

  • 86.4% India
  • 13.6% Money Market

Holdings by sector

  • 38.41% Financials
  • 18.23% Consumer Discretionary
  • 13.6% Net Current Assets
  • 10.12% Health Care
  • 7.96% Consumer Staples
  • 4.65% Energy
  • 3.89% Industrials
  • 3.14% Information Technology

Holdings by asset type

  • 86.4% Indian Equities
  • 13.6% Money Market

Individual holdings

  • 9.5% Bajaj Finance Ltd.
  • 7.3% YES BANK
  • 5.3% SUN PHARMACEUTICALS INDUSTRIES
  • 5.3% SUN PHARMACEUTICALS INDUSTRIES
  • 5.2% COX & KINGS LTD
  • 5.2% COX & KINGS LTD
  • 5% BAJAJ FINSERV
  • 5% BAJAJ FINSERV
  • 4.8% GLENMARK PHARMACEUTICALS
  • 4.8% GLENMARK PHARMACEUTICALS